EMLA™

EMLA®

EMLA® is a licensed topical anesthetic combining lidocaine 2.5% and prilocaine 2.5% in a eutectic mixture, originated by AstraZeneca and distributed in various markets by Aspen Pharma. It comes as a cream and as a patch, and clinics use it to numb intact skin before everything from a routine venipuncture to laser work. What separates it from a plain lidocaine cream is the eutectic formulation, which reaches a higher working concentration at the skin surface than either agent could alone. Practitioners who want to buy EMLA® online are usually weighing it against the aesthetic brand numbing products, and the sections below cover the formulation, how to apply it, its indications, regulatory status, and how it compares.

What Is EMLA® Cream? The Eutectic Lidocaine Prilocaine Anesthetic

EMLA® stands for Eutectic Mixture of Local Anesthetics, and the name describes exactly what the formulation does. Combining lidocaine 2.5% and prilocaine 2.5% creates a eutectic mixture with a lower melting point than either agent has on its own, which allows the two amide-type local anesthetics to exist as an oil-in-water emulsion rather than separate crystalline solids [1]. This matters clinically because the emulsion penetrates intact skin more effectively than either component alone could at the same concentration, delivering a higher effective local anesthetic concentration at the skin surface.

Once it’s on the skin, the lidocaine and prilocaine settle into the neuronal membranes and block the ion flux that a nerve needs to fire, which is what produces the numbing [1]. EMLA® is a licensed pharmaceutical, so practitioners who buy EMLA® cream need to source it in line with the regulatory rules that apply where they practice.

AstraZeneca developed the original formulation; Aspen Pharma handles distribution across a number of international markets.

EMLA® Products: Cream and Patch

EMLA® is available in two formats, and the right one depends largely on the procedure and clinical setting:

• EMLA® Cream is supplied in 5 g and 30 g tubes, depending on the market, with lidocaine 25 mg/g and prilocaine 25 mg/g. It is applied topically under an occlusive dressing and is the most widely available format, suited to a range of treatment areas and procedure sizes. This is the format most practitioners mean when they refer to EMLA® numbing cream or EMLA® lidocaine cream, and it is the format most clinics buy for general use.
• EMLA® Patch carries a fixed dose of 25 mg of lidocaine and 25 mg of prilocaine, with the occlusive dressing already part of the patch. It’s mainly used to numb the site before a venipuncture, and because there’s no separate dressing to apply, it saves a step. Departments running a lot of blood draws tend to prefer it for exactly that reason. Availability depends on the market.

How to Apply EMLA® Cream: Protocol and Occlusion

Correct application matters as much as the formulation itself when it comes to achieving reliable anesthesia. The standard protocol is straightforward:

• Apply a thick layer, roughly 1 to 2 g per 10 cm², to intact skin.
• Cover immediately with an occlusive dressing, such as Tegaderm or cling film.
• Leave in place for the recommended time based on the procedure.
• Remove the cream and dressing immediately before the procedure begins.

Onset under occlusion typically begins at 45 to 60 minutes, with full effect developing between 60 and 120 minutes [1]. For most skin procedures, a minimum of 60 minutes’ application is recommended; deeper anesthesia for procedures like laser or ablative treatments generally calls for 90 to 120 minutes. Maximum anesthetic effect under occlusion is reached at 2 to 3 hours, and once the cream is removed, the anesthetic effect typically persists for a further 1 to 2 hours [1]. EMLA® is a topical preparation, not an injectable, and should never be framed as one in patient-facing materials.

Clinical Indications and Treatment Areas

Where EMLA® has the most evidence behind it is venipuncture and IV cannulation. In a controlled trial in children, it cut both the pain and the technical difficulty of the venipuncture compared with no anesthetic at all, at standard needle gauges [3]. That trial is a big part of why EMLA® is still the reference point people reach for when the goal is reducing venipuncture pain, in adults as much as in children.

Beyond venipuncture, EMLA® is used across a range of aesthetic and minor surgical applications:

• Laser treatment, both ablative and non-ablative
• Pre-procedure anesthesia for microneedling and mesotherapy
• Electrolysis
• Minor skin surgery and other superficial skin procedures

EMLA® Efficacy in Heavily Pigmented Skin: What Practitioners Should Know

A reasonable question for any practitioner working across diverse patient populations is whether skin pigmentation affects how well EMLA® works. Earlier observations had suggested lidocaine/prilocaine cream might be less effective on heavily pigmented skin, prompting a dedicated controlled study to test the question directly.

Volunteers were sorted into three pigmentation groups, and each had lidocaine/prilocaine cream on one arm and placebo on the other for 60, 90, or 120 minutes before a venipuncture, with perceived pain scored on a visual analog scale afterward. At 60 minutes, the cream beat placebo for pain relief in every group, and the difference between the three pigmentation groups wasn’t significant. Stretching the application out to 120 minutes didn’t move the numbers either [4]. The takeaway is that EMLA® works across pigmentation types at normal application times, and the “it’s weaker on darker skin” idea doesn’t hold up against the controlled data.

None of that removes ordinary patient-to-patient variation in how well the cream penetrates. If a given patient is slower to numb, whatever their skin tone, the sensible move is to extend occlusion time within the approved range rather than to assume pigmentation is the reason.

Regulatory Status and OTC Availability

EMLA® is a licensed pharmaceutical topical anesthetic regulated under medicines and medical devices frameworks rather than as a cosmetic product. Its regulatory classification differs between countries, so healthcare professionals should always verify local requirements before recommending or supplying the product. Key considerations include:

• Market-specific classification: EMLA® cream is available as a pharmacy (P) medicine in many European markets for approved indications, including venipuncture and minor skin procedures.
• Prescription status: In other jurisdictions, EMLA® is classified as a prescription-only medicine (POM).
• Regulatory verification: Because OTC EMLA® cream availability varies by country, practitioners should confirm the current classification before they advise patients or order EMLA® online.
• Professional supply: Practitioners with questions about EMLA® availability or regulatory classification can consult Medical Spa Rx for product information and sourcing guidance where applicable.

EMLA® Compared to Aesthetic Brand Topical Anesthetics

EMLA® vs MESOESTETIC®

MESOESTETIC®’s numbing options are part of its wider skincare and mesotherapy range, mostly lidocaine-only creams somewhere in the 4 to 10% range, used to take the edge off before microneedling, laser, or a peel. There’s no prilocaine in them, so they never get the eutectic effect that lets EMLA® reach a higher working concentration at the skin surface off a lower total drug load. In most markets, MESOESTETIC® products are cosmeceuticals; EMLA® is a licensed pharmaceutical with approved indications on the label.

EMLA® vs SESDERMA®

SESDERMA®’s numbing entry, its Lidocaine Cream, is a single-agent lidocaine for use before aesthetic procedures but doesn’t have EMLA®’s eutectic formulation. Depending on the product and the market, SESDERMA® items are CE-marked cosmetics or medical devices rather than pharmaceuticals in EMLA®’s category. When the procedure is one where depth of anesthesia and documented efficacy actually matter, a venipuncture, minor surgery, laser, EMLA®’s pharmaceutical status and published evidence give practitioners firmer ground to stand on.

EMLA® vs FILLMED®

FILLMED®, part of the Filorga group, offers meso-anesthesia products within its mesotherapy range: topical lidocaine-based preparations designed to numb skin before injection protocols. These are aesthetic professional products rather than licensed pharmaceutical topical anesthetics. The comparison is most relevant to practitioners running mesotherapy protocols. EMLA® applied beforehand provides pharmaceutical-grade numbing with supporting efficacy data, whereas FILLMED®’s products are built specifically for pre-mesotherapy skin prep and may include other actives for that job. The regulatory footing differs: EMLA® is under a POM or OTC pharmaceutical framework, while FILLMED®’s range is a medical device or cosmetic in most markets.

EMLA® vs BCN

BCN, from Institut BCN, also offers topical numbing preparations within its mesotherapy range, aimed at making injection procedures more comfortable. They’re aesthetic-sector products with cosmetic or medical device status, not licensed anesthetics. EMLA® is the outlier in the set: a licensed pharmaceutical with a defined regulatory framework, approved indications, and published evidence across venipuncture, minor surgery, and skin procedures. If documented efficacy and pharmaceutical compliance are part of how a clinic chooses its numbing agent, that standing is what sets EMLA® apart here.

EMLA® vs MEDIDERMA®

MEDIDERMA® offers topical anesthetic creams and preparations within its professional aesthetic range, typically lidocaine-based. As with the others, these are cosmetic or medical device products rather than licensed pharmaceuticals. The distinction earns its keep in any setting where compliance gets audited. EMLA® is a POM or pharmacy-regulated product with real pharmaceutical approval, and the efficacy of EMLA® cream for reducing perceived pain has been documented across several procedure types in clinical trials, which is what practitioners lean on when the file has to show evidence.

Clinical Benefits of EMLA® for Aesthetic and Medical Practitioners

EMLA® has been in medical and aesthetic use long enough to be a known quantity, and clinics reach for it when they want predictable numbing before a procedure. A few things account for that. Its efficacy at reducing perceived pain is documented across dermatologic, aesthetic, and minor medical procedures in published trials [3][4], not asserted from a single study.

The dual-agent eutectic formula generally numbs deeper and more reliably than the single-agent lidocaine creams the aesthetic brands sell. Its licensed status makes the governance and audit side straightforward, which matters more than it sounds when compliance is being checked.

Having both a cream and a patch means the format can follow the procedure rather than the other way round. Between them, these EMLA® cream uses are why it keeps its place in both aesthetic and medical practice.

Storage and Handling

Keep EMLA® below 25°C, do not freeze, and keep the tube closed between uses. The labeling gives the shelf life, and once a tube is open, it should be used within the window the IFU specifies. There’s no cold chain to worry about, which makes shipping and handling simpler than it is for temperature-sensitive injectables. The usual pharmaceutical shipping and storage practices still apply, since the product still has to arrive intact.

EMLA® Price: What Practitioners Should Know

EMLA® is priced as a prescription pharmaceutical, and the cost may vary depending on the tube size (5 g or 30 g), supplier, market, and order volume. In addition to the unit price, healthcare professionals should consider factors such as applicable taxes, VAT classifications, shipping costs, and the wholesale licensing requirements that practices confirm before they buy EMLA® wholesale, which can differ by country or region.

Evaluating these procurement factors helps produce a more accurate estimate of overall cost when planning inventory. The considerations that apply when practitioners purchase EMLA® online — regulatory classification, documentation, and storage handling — matter as much as headline price, and Medical Spa Rx can provide product and sourcing information on request.

Side Effects and Contraindications

Common EMLA® side effects are localized and generally transient: erythema, pallor, and edema at the application site, along with transient skin blanching in some patients [1]. A more specific risk to be aware of is methemoglobinemia, particularly with prolonged use, application over large areas, or in neonates and patients with G6PD deficiency, since prilocaine metabolism is the relevant mechanism here [1].

Contraindications include:

• Known hypersensitivity to lidocaine, prilocaine, or other amide-type local anesthetics
• Congenital or idiopathic methemoglobinemia
• Neonates under 37 weeks gestational age, without specific medical supervision

EMLA® should also be avoided on open wounds, infected or inflamed skin, and mucous membranes, unless product labeling specifically permits that use for the indication in question [1].

How to Find Information on Buying EMLA®

EMLA®’s regulatory status as prescription-only or pharmacy-regulated depends on the market, so sourcing should always start with confirming the product’s current regulatory classification in your jurisdiction. From there, practitioners should work through authorized distributors rather than informal supply channels, particularly given the pharmaceutical classification and the shipping and handling standards that apply to licensed medicines.

The requirements to buy EMLA® online differ by jurisdiction, and licensed practitioners are generally best served by confirming their local regulatory category before arranging supply. For clinics weighing wholesale routes, representatives can explain what verified practitioners should confirm before they buy EMLA® wholesale, including regulatory documentation and distributor credentials.

If you want to buy EMLA® online, Medical Spa Rx representatives can help with guidance on availability.

Frequently Asked Questions

What is EMLA® cream?

EMLA® is a topical anesthetic cream containing lidocaine 2.5% and prilocaine 2.5% in a eutectic mixture, which allows a higher effective skin concentration than either agent alone. It is a licensed pharmaceutical product from AstraZeneca/Aspen, used to numb skin before minor procedures.

What is EMLA® cream used for?

Skin anesthesia prior to venipuncture, IV cannulation, minor surgical procedures, laser treatment, microneedling, and other superficial skin procedures.

What are EMLA® cream ingredients?

Lidocaine 2.5% and prilocaine 2.5% in a eutectic oil-in-water emulsion, with excipients including carbomer, sodium hydroxide, and purified water. The eutectic mixture achieves a lower combined melting point, which enables penetration through intact skin [1].

How long does EMLA® take to work?

Onset under occlusion is typically 60 minutes for most skin procedures, extending to 90 to 120 minutes for deeper anesthesia such as laser treatment. Maximum effect is reached at 2 to 3 hours, and anesthesia typically persists for 1 to 2 hours after the cream is removed [1]. To apply, cover intact skin with the cream, seal with an occlusive dressing, and leave in place for the recommended time.

Is EMLA® cream available over the counter?

OTC and pharmacy status varies by market. In many EU markets, EMLA® is available as a pharmacy (P) medicine without prescription for specified indications; in others, it is prescription-only. Availability should be verified against the practitioner’s own country of practice.

Does EMLA® work on heavily pigmented skin?

A controlled study testing this question directly found that lidocaine/prilocaine cream significantly reduced venipuncture pain regardless of skin pigmentation type, with no significant difference in efficacy across pigmentation groups at standard application times [4]. Individual variation is still worth accounting for clinically, but the evidence does not support a fixed efficacy gap by pigmentation type.

Is there an EMLA® patch?

Yes. The EMLA® Patch delivers lidocaine 25 mg and prilocaine 25 mg per patch and is available in some markets as an alternative to cream for venipuncture site anesthesia. It provides a measured dose and removes the need for a separate occlusive dressing. Availability varies by market.

Where can practitioners find information on buying EMLA®?

Practitioners seeking guidance before they buy EMLA® online can reach out to Medical Spa Rx for information about product availability and the sourcing options open to licensed healthcare professionals.

The page and all of its displayed contents are for medical professionals, designed to inform only, and not as a replacement for medical advice.

References

[1] European Medicines Agency (EMA). EMLA Cream: Article 30 Referral, Annex III (Summary of Product Characteristics). https://www.ema.europa.eu/en/documents/referral/emla-cream-article-30-referral-annex-iii_en.pdf

[2] The Aspen Group. Product Monograph, EMLA® Cream, EMLA® Patch. Lidocaine 2.5% and Prilocaine 2.5% cream and patch topical anesthetic for dermal analgesia. Updated August 8, 2017. https://pdf.hres.ca/dpd_pm/00040608.PDF

[3] Cooper CM, Gerrish SP, Hardwick M, Kay R. EMLA cream reduces the pain of venepuncture in children. Eur J Anaesthesiol. 1987;4(6):441-448. https://pubmed.ncbi.nlm.nih.gov/3328685/

[4] Riendeau LA, Bennett D, Black-Noller G, Fan L, Scavone JM. Evaluation of the analgesic efficacy of EMLA cream in volunteers with differing skin pigmentation undergoing venipuncture. Reg Anesth Pain Med. 1999;24(2):165-169. doi:10.1016/s1098-7339(99)90079-2. https://pubmed.ncbi.nlm.nih.gov/10204904/

[5] US Food and Drug Administration. EMLA Cream (lidocaine 2.5% and Prilocaine 2.5%) Label. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019941s021lbl.pdf